• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA NEUROSCIENCES PR BIOPATCH, UNKNOWN SIZE/PRODUCT ID; ANTIMICROBIAL PRODUCTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA NEUROSCIENCES PR BIOPATCH, UNKNOWN SIZE/PRODUCT ID; ANTIMICROBIAL PRODUCTS Back to Search Results
Catalog Number XXX-BIOPATCH
Device Problems Improper or Incorrect Procedure or Method (2017); Device Operates Differently Than Expected (2913)
Patient Problem Unspecified Infection (1930)
Event Type  Injury  
Manufacturer Narrative
The device involved in the reported incident is not available for evaluation.An investigation has been initiated based on the reported information.
 
Event Description
World neurosurgery (2017) published "a simple infection control protocol durably reduces external ventricular drain infections to near-zero levels" this report is a retrospective analysis of evds placed in the intensive care unit of a tertiary neurosurgical center over an additional 4 year follow-up period.Evd dressing in the protocol involves tunneling by 3e5 cm, a question-mark array of surgical staples to secure the catheter, tincture of benzoin, a chlorhexidine-eluting patch (biopatch), a large transparent dressing (tegaderm; 3m medical,), and adhesive strips (steristrips; 3m medical).Results: in the 4-year follow-up period, 189 evds were placed in 173 patients.The previously observed decrease in cerebrospinal fluid culture positivity from 9.8% in the baseline period to 0.8% in the first 3 years of the protocol period continued in the 4-year follow-up period (0%, 0 of 189 evd placements, 0 per 1000 catheter-days; p < 0.001 compared with baseline).The previously observed decrease in the rate of ventriculitis from 6.3% to 0.8% also continued in the follow-up period (0%, 0 of 189 evd placements, 0 per 1000 catheter-days).Over the total 7 years of protocol use, the rate of culture positivity was 0.3% (1 of 308 evd placements, 0.29 per 1000 catheter-days) and the rate of ventriculitis was 0.3% (1 of 308 evd placements, 0.29 per 1000 catheter-days).The only observed infection over 7 years occurred in a patient who removed their own evd.
 
Manufacturer Narrative
Integra has completed their internal investigation on january 17, 2018.Results: evaluation of returned device; a failure analysis from the reported event is not possible.No catalog and lot number was provided for evaluation and no biopatch unit was reported to be returned.Dhr review; no device history record (dhr) was possible since no lot number was identified by the customer.Complaints history; after reviewing the integra complaint system since december 2015 to december 2017, eight (8) complaints (including the one being investigated) related to the condition ¿observed infection¿ have been reported on biopatch family.Conclusion: no assignable causes that could be associated to the reported condition were found in the biopatch manufacturing or packaging process based on the review of current practices, scars, capas, and ncrs history.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BIOPATCH, UNKNOWN SIZE/PRODUCT ID
Type of Device
ANTIMICROBIAL PRODUCTS
Manufacturer (Section D)
INTEGRA NEUROSCIENCES PR
road 402 north, km 1.2
road 402 north, km 1.2
anasco PR 00610
Manufacturer (Section G)
INTEGRA NEUROSCIENCES PR
road 402 north, km 1.2
anasco PR 00610
Manufacturer Contact
sonia irizarry
311 enterprise drive
plainsboro, NJ 08536
6099362393
MDR Report Key7143150
MDR Text Key95727541
Report Number2648988-2017-00067
Device Sequence Number1
Product Code FRO
Combination Product (y/n)N
PMA/PMN Number
K003229
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/28/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/22/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberXXX-BIOPATCH
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received01/17/2018
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
-
-